INVESTOR RIGHTS AND LOCK-UP AGREEMENTInvestor Rights and Lock-Up Agreement • August 14th, 2023 • Carmell Corp • Surgical & medical instruments & apparatus
Contract Type FiledAugust 14th, 2023 Company IndustryTHIS INVESTOR RIGHTS AND LOCK-UP AGREEMENT (this “Agreement”) is entered into as of July 14, 2023, by and among Carmell Therapeutics Corporation (f/k/a Alpha Healthcare Acquisition Corp. III), a Delaware corporation, (the “Company”) and the parties listed as Investors on Schedule I hereto (each, including any person or entity who hereinafter becomes a party to this Agreement pursuant to Section 8.2, an “Investor” and collectively, the “Investors”).
INVESTOR RIGHTS AND LOCK-UP AGREEMENTInvestor Rights and Lock-Up Agreement • September 22nd, 2022 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledSeptember 22nd, 2022 Company Industry JurisdictionThis INVESTOR RIGHTS AND LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of ____________ ____, 2022 by and among Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”) and the investor on the signature page hereto.
INVESTOR RIGHTS AND LOCK-UP AGREEMENTInvestor Rights and Lock-Up Agreement • August 31st, 2021 • Nevada
Contract Type FiledAugust 31st, 2021 JurisdictionThis INVESTOR RIGHTS AND LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of , 2021 by and among ACRES TECHNOLOGY, a Nevada corporation (the “Company”), the parties listed on Exhibit A attached hereto (the “Investors”) and John Acres and Noah Acres (the “Key Owners” and together with any subsequent stockholders or option holders, or any transferees, who become parties hereto as “Investors” or “Key Owners,” collectively, the “Holders”).
INVESTOR RIGHTS AND LOCK-UP AGREEMENTInvestor Rights and Lock-Up Agreement • July 31st, 2020 • Immatics N.V. • Biological products, (no disgnostic substances)
Contract Type FiledJuly 31st, 2020 Company IndustryTHIS INVESTOR RIGHTS AND LOCK-UP AGREEMENT (this “Agreement”) is entered into as of July 1, 2020, by and among Immatics N.V., a Dutch public limited liability company (the “Company”), the parties listed as Investors on Schedule I hereto (each, an “Investor” and collectively, the “Investors”).